Open access · CC-BY
via OpenAlex
Strategies for senolytic drug discovery
Helen Power, Peter Valtchev, Fariba Dehghani, Aaron Schindeler
Aging Cell · 2023 · ▲ 87 citations
Abstract
Senolytics(definition) are a category of drugs that reduce the impact of cellular senescence(definition), an effect associated with a range of chronic and age-related diseases. Since the discovery of the first senolytics in 2015, the number of known senolytic agents has grown dramatically. This review discusses the broad categories of known senolytics-kinase inhibitors, Bcl-2 family protein inhibitors, naturally occurring polyphenols, heat shock protein inhibitors, BET family protein inhibitors, P53 stabilizers, repurposed anti-cancer drugs, cardiac steroids, PPAR-alpha agonists, and antibiotics. The approaches used to screen for new senolytics are articulated including a range of methods to induce senescence, different target cell types, various senolytic assays, and markers. The choice of methods can greatly influence the outcomes of a screen, with high-quality screens featuring robust systems, adequate controls, and extensive validation in alternate assays. Recent advances in single-cell analysis and computational methods for senolytic identification are also discussed. There is significant potential for further drug discovery, but this will require additional research into drug targets and mechanisms of actions and their subsequent rigorous evaluation in pre-clinical models and human trials.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.13948
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Power, H., Valtchev, P., Dehghani, F., & Schindeler, A. (2023). Strategies for senolytic drug discovery. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13948
Vancouver
Power H, Valtchev P, Dehghani F, Schindeler A. Strategies for senolytic drug discovery. Aging Cell. 2023. doi:10.1111/acel.13948.
BibTeX
@article{helen2023Strate,
title = {Strategies for senolytic drug discovery},
author = {Helen Power and Peter Valtchev and Fariba Dehghani and Aaron Schindeler},
journal = {Aging Cell},
year = {2023},
doi = {10.1111/acel.13948},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2026
Open access · CC-BY
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
Aging cell 2026
Citation only
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan.
Cells 2023
Open access · CC-BY
Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies
Aging Cell 2024
Open access · CC-BY
Senescence landscape in the liver following sepsis and senolytics as potential therapeutics
Open Biology 2022
Open access · CC-BY
From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
Cells 2025
Open access · CC-BY